EcoDrugPlus

Retinoid X Receptor Alpha

Ensembl ID : ENSDLEG00000004352
Gene Symbol: RXRA
3 Cross references
249 Possible Orthologues:

Retinoid X Receptor Beta

Ensembl ID : ENSDLEG00000008760
Gene Symbol: RXRB
3 Cross references
215 Possible Orthologues:

Retinoid X Receptor Gamma

Ensembl ID : ENSDLEG00000017605
Gene Symbol: RXRG
3 Cross references
276 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSDLEG00000010852
Gene Symbol: RPL11
3 Cross references
182 Possible Orthologues:

Ribosomal Protein L14

Ensembl ID : ENSDLEG00000010250
Gene Symbol: RPL14
3 Cross references
278 Possible Orthologues:

Ribosomal Protein L15

Ensembl ID : ENSDLEG00000013495
Gene Symbol: RPL15
4 Cross references
201 Possible Orthologues:

Ribosomal Protein L18

Ensembl ID : ENSDLEG00000001097
Gene Symbol: RPL18
3 Cross references
276 Possible Orthologues:

Ribosomal Protein L19

Ensembl ID : ENSDLEG00000014387
Gene Symbol: RPL19
3 Cross references
244 Possible Orthologues:

Ribosomal Protein L22

Ensembl ID : ENSDLEG00000008445
Gene Symbol: RPL22
3 Cross references
222 Possible Orthologues:

Ribosomal Protein L24

Ensembl ID : ENSDLEG00000008702
Gene Symbol: RPL24
3 Cross references
244 Possible Orthologues:

Ribosomal Protein L27

Ensembl ID : ENSDLEG00000016666
Gene Symbol: RPL27
3 Cross references
187 Possible Orthologues:

Ribosomal Protein L29

Ensembl ID : ENSDLEG00000021882
Gene Symbol: RPL29
3 Cross references
338 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).